Health Canada RSS - MedEffect Canada - Health Product InfoWatchhttps://www.canada.ca/content/dam/hc-sc/migration/hc-sc/rss/dhp-mps/hpiw-ivps-eng.xmlHealth Canadahttps://www.canada.ca/en/health-canada.html2015-01-29T15:50:32-05:00https://www.canada.ca/en/health-canada.html/images/templates/wmms.gifhttps://www.canada.ca/en/health-canada.html/images/common/sm-rss.gifThe Health Product InfoWatch will be published monthly in an easy to read format that includes a monthly recap of health product advisories and summary safety reviews, as well as a growing selection of new health product safety information.The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch - January 2019https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-january-2019.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2019-01-31T16:35:00-05:002019-01-31T16:35:00-05:00Health Product InfoWatch - January 2019The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – December 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-december-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-12-20T14:45:00-05:002018-12-20T14:45:00-05:00Content: Announcements; Opioid updates; Product monograph updates: Gilenya; Imuran; Prezcobix; Symtuza; VimpatThe material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – November 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-november-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-11-28T14:30:00-05:002018-11-28T14:30:00-05:00Content: Review article: Lamotrigine; Product monograph updates: Kayexalate; Resonium Calcium and Rifadin; Notice of market authorization with conditions: Folotyn The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – October 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-october-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-10-24T15:45:00-04:002018-10-24T15:45:00-04:00Content: Dose prescribing error alert: Ocaliva (obeticholic acid); Product monograph update: Lenvima (lenvatinib)The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – September 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-september-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-09-28T09:00:00-04:002018-09-28T09:00:00-04:00Content: Announcements; Monthly Recap; Product monograph update: Flarex (fluorometholone acetate ophthalmic suspension); Product Monograph Update: Orgalutran (ganirelix acetate injection)The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch - August 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-august-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-08-29T15:10:00-04:002018-08-29T15:10:00-04:00Content: Monthly Recap; Product monograph updates : Avapro (irbesartan) and Avalide (irbesartan and hydrochlorothiazide; Product Monograph Update: Tactupump and Tactupump Forte (adapalene and benzoyl peroxide); Notice of market authorization with conditions: Alunbrig (brigatinib)The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – June 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-june-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-06-28T15:40:00-04:002018-06-28T15:40:00-04:00Content: Announcement: Opioid marketing and advertising consultations ; Monthly Recap ; Product monograph update: Proscar and Propecia (finasteride) ; Notice of Market Authorization with Conditions: Lynparza (olaparib) tablet formulationThe material on this web site is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – May 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-may-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-05-31T12:45:00-05:002018-05-31T12:45:00-05:00Content: Announcement: New regulations to provide better information for patients on the safe use of opioid medications ; Monthly Recap ; Product monograph updates: Dipeptidylpeptidase-4 (DPP-4) Inhibitors ; Elavil (amitriptyline hydrochloride) ; Gadolinium-Based Contrast Agents ; Imitrex injection (sumatriptan succinate) ; Revlimid (lenalidomide) ; Zydelig (idelalisib) ; Notices of Market Authorization with Conditions: Bavencio (avelumab) ; Imfinzi (durvalumab)The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch - April 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-april-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-04-25T16:40:00-05:002018-04-25T16:40:00-05:00Monthly Recap; Product monograph update: Cardizem CD (diltiazem hydrochloride); Vaccine safety biannual summary: Report for January 1, 2017 to June 30, 2017The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch - March 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-march-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-03-28T15:00:00-05:002018-03-28T15:00:00-05:00Content: Monthly Recap; Case report: Combined use of the EasyCare hospital bed and over-bed table - risk of patient entrapmentThe material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – February 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-february-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-02-22T13:30:00-05:002018-02-22T13:30:00-05:00Content: Monthly Recap ; Product monograph update: Alcaine (proparacaine hydrochloride); Product monograph update: Concerta (methylphenidate hydrochloride); Product monograph update: Zoloft (sertraline hydrochloride)The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – January 2018https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-january-2018.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2018-01-25T12:40:00-05:002018-01-25T12:40:00-05:00Content: Monthly Recap ; Product monograph update: Ofev (nintedanib); Announcement: Consultation on naming of biologic drugsThe material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – November 2017https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-november-2017.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2017-11-29T12:00:00-05:002017-11-29T12:00:00-05:00Content: Monthly Recap; Product monograph update: Clobex shampoo (clobetasol propionate solution 0.05% w/w)The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – October 2017https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-october-2017.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2017-10-26T15:15:00-05:002017-10-26T15:15:00-05:00Content: Monthly Recap; Product monograph update: Erythrocin I.V. (erythromycin lactobionate); Product monograph update: Mefloquine; Product monograph update: Proton Pump InhibitorsThe material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.Health Product InfoWatch – September 2017https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-september-2017.htmlHealth Canadahttps://www.canada.ca/en/health-canada.html2017-09-28T10:15:00-05:002017-09-28T10:15:00-05:00Content: Monthly Recap; Product monograph update: Keppra (levetiracetam); Product monograph update: Rifadin (rifampine);The material on this website is covered by the provisions of the Copyright Act, by Canadian laws, policies, regulations and international agreements. Such provisions serve to identify the information source and, in specific instances, to prohibit reproduction of materials without copyright clearance.